{"Symbol": "VRTX", "AssetType": "Common Stock", "Name": "Vertex Pharmaceuticals Inc", "Description": "Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.", "CIK": "875320", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "BIOTECHNOLOGY", "Address": "50 NORTHERN AVENUE, BOSTON, MA, UNITED STATES, 02210", "OfficialSite": "https://www.vrtx.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-12-31", "MarketCapitalization": "126008320000", "EBITDA": "4866000000", "PERatio": "32.06", "PEGRatio": "0.58", "BookValue": "73.49", "DividendPerShare": "None", "DividendYield": "None", "EPS": "15.33", "RevenuePerShareTTM": "46.94", "ProfitMargin": "0.329", "OperatingMarginTTM": "0.396", "ReturnOnAssetsTTM": "0.122", "ReturnOnEquityTTM": "0.225", "RevenueTTM": "12001300000", "GrossProfitTTM": "6440500000", "DilutedEPSTTM": "15.33", "QuarterlyEarningsGrowthYOY": "0.329", "QuarterlyRevenueGrowthYOY": "0.095", "AnalystTargetPrice": "525.54", "AnalystRatingStrongBuy": "4", "AnalystRatingBuy": "19", "AnalystRatingHold": "6", "AnalystRatingSell": "1", "AnalystRatingStrongSell": "1", "TrailingPE": "32.06", "ForwardPE": "25.13", "PriceToSalesRatioTTM": "10.5", "PriceToBookRatio": "6.68", "EVToRevenue": "10.0", "EVToEBITDA": "25.79", "Beta": "0.319", "52WeekHigh": "519.68", "52WeekLow": "362.5", "50DayMovingAverage": "460.32", "200DayMovingAverage": "435.56", "SharesOutstanding": "253719000", "SharesFloat": "253181000", "PercentInsiders": "0.187", "PercentInstitutions": "98.766", "DividendDate": "None", "ExDividendDate": "None"}